Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Capital Reinvestment Ratio
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Capital Reinvestment Ratio of 0.46x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥69.15 Million) in capital expenditures (CN¥32.02 Million). Check Anhui Fengyuan Pharmaceutical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Anhui Fengyuan Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Anhui Fengyuan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods. For the full cash flow conversion analysis, see Anhui Fengyuan Pharmaceutical Co Ltd (000153) cash flow conversion.
Annual Capital Reinvestment Ratio for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. See Anhui Fengyuan Pharmaceutical Co Ltd (000153) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.85x | CN¥119.30 Million | CN¥220.61 Million | ▲ +62.1% |
| 2024 | 1.14x | CN¥126.24 Million | CN¥144.02 Million | ▲ +91.1% |
| 2023 | 0.60x | CN¥254.75 Million | CN¥152.12 Million | ▲ +221.3% |
| 2022 | 0.19x | CN¥439.99 Million | CN¥81.76 Million | ▼ -71.9% |
| 2021 | 0.66x | CN¥237.88 Million | CN¥157.36 Million | ▲ +1.5% |
| 2020 | 0.65x | CN¥292.75 Million | CN¥190.74 Million | ▼ -70.4% |
| 2019 | 2.20x | CN¥66.21 Million | CN¥145.62 Million | ▲ +507.0% |
| 2018 | 0.36x | CN¥233.59 Million | CN¥84.63 Million | ▼ -60.4% |
| 2017 | 0.92x | CN¥52.40 Million | CN¥47.99 Million | ▲ +223.2% |
| 2016 | 0.28x | CN¥78.21 Million | CN¥22.17 Million | ▼ -74.4% |
| 2015 | 1.11x | CN¥45.50 Million | CN¥50.33 Million | ▼ -93.4% |
| 2014 | 16.73x | CN¥10.51 Million | CN¥175.86 Million | ▲ +703.5% |
| 2012 | 2.08x | CN¥45.65 Million | CN¥95.06 Million | ▲ +64.1% |
| 2011 | 1.27x | CN¥55.06 Million | CN¥69.86 Million | ▼ -22.2% |
| 2010 | 1.63x | CN¥55.04 Million | CN¥89.75 Million | ▼ -29.0% |
| 2009 | 2.30x | CN¥32.41 Million | CN¥74.42 Million | ▲ +262.3% |
| 2008 | 0.63x | CN¥49.82 Million | CN¥31.58 Million | ▼ -0.4% |
| 2007 | 0.64x | CN¥55.26 Million | CN¥35.18 Million | ▼ -83.1% |
| 2006 | 3.77x | CN¥36.27 Million | CN¥136.67 Million | ▲ +268.4% |
| 2005 | 1.02x | CN¥34.88 Million | CN¥35.68 Million | ▼ -88.3% |
| 2002 | 8.73x | CN¥10.48 Million | CN¥91.40 Million | ▲ +8.1% |
| 2001 | 8.07x | CN¥23.57 Million | CN¥190.24 Million | ▲ +77.3% |
| 2000 | 4.55x | CN¥25.88 Million | CN¥117.82 Million | ▲ +0.5% |
| 1999 | 4.53x | CN¥1.01 Million | CN¥4.59 Million | — |